Skip to main content
Year archive

RECCE PHARMACEUTICALS LTD — 2016 filings

All 69 regulatory filings released by RECCE PHARMACEUTICALS LTD (RCE) in 2016, sourced directly from the official regulator.

69 Filings
2016 Period
2016 filings (69)
Filing Released Lang
Encouraging anti-viral activity for lead compound RECCE 327 3 pages 296.7KB
Regulatory Filings
2016-12-19 English
Appendix 3B 9 pages 310.8KB
Regulatory Filings
2016-11-24 English
Results of Meeting 2 pages 467.4KB
Regulatory Filings
2016-11-22 English
Director Resignation 2 pages 183.2KB
Regulatory Filings
2016-11-21 English
AGM Presentation 18 pages 1.0MB
Regulatory Filings
2016-11-21 English
Pre-clinical toxicology and efficacy testing 2 pages 185.3KB
Regulatory Filings
2016-11-01 English
Operational Update and Quarterly Cash Flow 7 pages 396.3KB
Regulatory Filings
2016-10-30 English
Notice of Annual General Meeting/Proxy Form 23 pages 927.9KB
Regulatory Filings
2016-10-20 English
Annual Report to shareholders 78 pages 5.4MB
Regulatory Filings
2016-10-20 English
Change of Director's Interest Notice 2 pages 219.8KB
Regulatory Filings
2016-09-12 English
Appendix 4E and Financial Report 63 pages 1.5MB
Regulatory Filings
2016-08-24 English
Dose Ranging in Mice - Repeated Success 4 pages 452.2KB
Regulatory Filings
2016-08-14 English
Broker Presentation 25 pages 2.3MB
Regulatory Filings
2016-08-07 English
Change in substantial holding 2 pages 1.4MB
Regulatory Filings
2016-07-31 English
Appendix 4C - quarterly 5 pages 365.4KB
Regulatory Filings
2016-07-28 English
Manufacturing Milestones and New Head Office 3 pages 594.9KB
Regulatory Filings
2016-07-27 English
Successful Test Results for Genetic Toxicity 2 pages 591.2KB
Regulatory Filings
2016-07-19 English
Appendix 3B 9 pages 462.5KB
Regulatory Filings
2016-07-14 English
Change of Director's Interest Notice 3 pages 493.3KB
Regulatory Filings
2016-07-14 English
Anti-viral Activity 3 pages 511.1KB
Regulatory Filings
2016-07-12 English
Update on Testing Schedules 2 pages 460.1KB
Regulatory Filings
2016-06-20 English
Appendix 3B 9 pages 461.6KB
Regulatory Filings
2016-06-13 English
Appendix 3B 13 pages 646.4KB
Regulatory Filings
2016-06-06 English
Pharma Executive Appointed to Recce Board 2 pages 215.0KB
Regulatory Filings
2016-05-26 English
Encouraging Results from Safety Test 3 pages 627.2KB
Regulatory Filings
2016-05-24 English
Shares to be released from Escrow 1 page 217.8KB
Regulatory Filings
2016-05-22 English
Director Appointment/Resignation 2 pages 383.5KB
Regulatory Filings
2016-05-15 English
Shares to be Released from Escrow 1 page 217.6KB
Regulatory Filings
2016-05-09 English
Recce - The Way Forward 2 pages 254.2KB
Regulatory Filings
2016-05-02 English
Appendix 4C - quarterly 6 pages 384.5KB
Regulatory Filings
2016-04-26 English
Progress Update 8 pages 1.0MB
Regulatory Filings
2016-04-10 English
Final Directors Interest Notice 4 pages 887.2KB
Regulatory Filings
2016-04-10 English
International Trade Mark Registrations 4 pages 580.6KB
Regulatory Filings
2016-04-05 English
Anti-cancer Activities 4 pages 377.7KB
Regulatory Filings
2016-03-13 English
Amendment to Appendix 3B 14 pages 794.8KB
Regulatory Filings
2016-02-28 English
Appendix 4D and Half Year Financial Statements 18 pages 819.0KB
Regulatory Filings
2016-02-25 English
Becoming a substantial holder 2 pages 1.5MB
Regulatory Filings
2016-02-16 English
Conversion of Performance Shares 1 page 183.0KB
Regulatory Filings
2016-02-15 English
Appendix 3B 13 pages 647.4KB
Regulatory Filings
2016-02-15 English
Change of Director's Interest Notice 16 pages 2.4MB
Regulatory Filings
2016-02-15 English
Efficacy without Toxicity 2 pages 254.1KB
Regulatory Filings
2016-02-01 English
Appendix 4C - quarterly 5 pages 364.0KB
Regulatory Filings
2016-01-28 English
Becoming a substantial holder 3 pages 430.8KB
Regulatory Filings
2016-01-27 English
RECCE Antibiotic kills TB and Gonorrhoea 1 page 227
Regulatory Filings
2016-01-26 English
Becoming a substantial holder 2 pages 1.4MB
Regulatory Filings
2016-01-24 English
Becoming a substantial holder 2 pages 1.5MB
Regulatory Filings
2016-01-24 English
Broker Presentation 28 pages 3.0MB
Regulatory Filings
2016-01-17 English
Patent Granted in China 1 page 108.4KB
Regulatory Filings
2016-01-14 English
Additional Patent Developments 1 page 106.4KB
Regulatory Filings
2016-01-14 English
RECCE Trademark Registered 1 page 107.6KB
Regulatory Filings
2016-01-14 English
RECCE Antiobiotic Equal/Better than Commercial Antibiotic 2 pages 191.9KB
Regulatory Filings
2016-01-14 English
Initial Director's Interest Notice 2 pages 205.7KB
Regulatory Filings
2016-01-14 English
Initial Director's Interest Notice 2 pages 205.4KB
Regulatory Filings
2016-01-14 English
Initial Director's Interest Notice 2 pages 205.1KB
Regulatory Filings
2016-01-14 English
Initial Director's Interest Notice 2 pages 206.6KB
Regulatory Filings
2016-01-14 English
Initial Director's Interest Notice 2 pages 205.5KB
Regulatory Filings
2016-01-14 English
Admission to Official List 1 page 114.1KB
Regulatory Filings
2016-01-12 English
ASX Notice 2 pages 288.8KB
Regulatory Filings
2016-01-12 English
Pre-Quotation Disclosure 1 page 116.6KB
Regulatory Filings
2016-01-12 English
Distribution Schedule 1 page 45.7KB
Regulatory Filings
2016-01-12 English
Top 20 shareholders 1 page 45.8KB
Regulatory Filings
2016-01-12 English
Appendix 1A and Information Form and Checklist 18 pages 723.2KB
Regulatory Filings
2016-01-12 English
Prospectus 118 pages 2.5MB
Regulatory Filings
2016-01-12 English
Constitution 69 pages 435.2KB
Regulatory Filings
2016-01-12 English
Finncial Accounts - 30 June 2013, 30 June 2014, 30 June 2015 33 pages 15.6MB
Regulatory Filings
2016-01-12 English
Securities Trading Policy 8 pages 207.4KB
Regulatory Filings
2016-01-12 English
Restricted Securities Statement 1 page 216.7KB
Regulatory Filings
2016-01-12 English
Terms and conditions of Company's performance shares 2 pages 25.4KB
Regulatory Filings
2016-01-12 English
Patent Family Confirmations 1 page 184.8KB
Regulatory Filings
2016-01-12 English